Chemical industry – Page 16
-
ResearchMapping metabolite disturbances by drugs
High-throughput metabolomic profiling gives insight into unpredictable drug effects
-
NewsChemical sciences workforce growth could outstrip rest of UK over next 10 years
Royal Society of Chemistry report says support for schools, universities and industry is needed for sector to thrive
-
BusinessNew Purdue bankruptcy deal cuts out Sacklers’ legal immunity
$7.4 billion proposal will fund support for victims of US opioid crisis
-
OpinionMaintaining mental balance
Finding solace from human affairs in the eypiece of a telescope or microscope
-
BusinessEight workers dead in Indian munitions factory explosion
Seven others injured during incident at state-owned explosives plant
-
BusinessJ&J’s Intra-Cellular deal could signal more mega-mergers for 2025
£15 billion deal for neuroscience biotech aims to replace revenues from patent expiries
-
BusinessRed 3 dye banned in US food and drugs
Additive was already banned in US cosmetics and around the world
-
OpinionSharing the burden of contraception could also mean sharing the risk
What if risk assessments for contraception considered the sum of risk to both members of a couple?
-
FeatureOn the trail of the male contraceptive pill
As multiple novel male contraception compounds enter clinical trials, is family planning about to undergo a second revolution? James Mitchell Crow reports
-
OpinionRobots queuing up to fail
Claims of an AI revolution in drug discovery are missing the biggest problem
-
OpinionThe right level of trust in the scientific literature
An overreliance on what’s gone before can hinder innovation
-
NewsMaterials strategy for UK needs chemistry to succeed and create new industries
Ten-year plan proposed by Henry Royce Institute aims to boost productivity and support the circular economy
-
FeatureThe promise of drugs that send proteins to the shredder
Andy Extance charts how research into revolutionary targeted protein degradation therapies is moving from serendipity to strategic discovery
-
CareersRe-establishing my scientist identity in industry
How to embrace a career transition outside of academia
-
NewsEPA concludes that formaldehyde presents ‘unreasonable risk’ to human health
Agency will propose new regulatory actions to reduce health risks associated with the compound’s industrial uses
-
BusinessUS state charges Lockhart director over river chemical release
Bankrupt firm’s leader accused of endangering the public and altering public records
-
BusinessPFAS manufacturers sued for deceptive marketing in US
Texas attorney general accuses 3M and DuPont of knowingly concealing health risks
-
BusinessChemicals industry roundup 2024
Europe continues to struggle with high energy and feedstock costs, while US and Asia negotiate supply gluts
-
BusinessPharmaceuticals roundup 2024
Diabetes and weight loss drugs have surged in popularity, revealing supply frailties
-
BusinessOpposition to lithium mines hampers green technology supply chain
Europe and US seek to escape Chinese dominance in critical minerals